Alkermes | Investor Presentation Deck | 32 slides · page 29 of 32
The chart illustrates the shift from a single-product revenue base to a more diversified portfolio including VIVITROL, ARISTADA, VUMERITY, and LYBALVI.
Research note · kpi_overview · analyze_data · sparse density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 disclaimer 1/1 legend 1/1 title 1/1
Components 4
bar-stacked disclaimer legend headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.